Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Pittsburgh
BioEclipse Therapeutics
Fate Therapeutics
Fate Therapeutics
City of Hope Medical Center
Rutgers, The State University of New Jersey